Recombinant influenza viruses for vaccines and gene therapy

Details for Australian Patent Application No. 2005202386 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Kawaoka, Yoshihiro; Neumann, Gabriele

Agent Spruson & Ferguson

Pub. Number AU-B-2005202386

Parent 40733

Filing date 27 May 2005

Wipo publication date 23 June 2005

Acceptance publication date 3 January 2008

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

16 June 2005 Complete Application Filed

23 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202386

3 January 2008 Application Accepted

  Published as AU-B-2005202386

1 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202387-Indolylmaleimide derivatives as protein kinase C inhibitors

2005202385-Kit for chondrocyte cell transplantation